Morgan Stanley's Chemical Stock Calls Diverge: Deepak Nitrite, Aarti and PI Industries
Morgan Stanley's latest Indian chemicals-sector research takes different positions on Deepak Nitrite, Aarti Industries and PI Industries, reflecting distinct earnings prospects across the specialty chemicals industry. In its October 20, 2026 report, the brokerage retained an Overweight rating on Deepak Nitrite, upgraded Aarti Industries to Equal-weight and downgraded PI Industries, according to published reports.
The changes point to a company-specific assessment of margins, product competition, feedstock access and execution rather than a broad-based call on every chemical stock. All ratings and price targets below are Morgan Stanley's reported research views, not guaranteed outcomes or recommendations from TradeKaizen.
Ratings and Price Targets
| Company | Reported rating change | Previous target | New target |
|---|---|---|---|
| Deepak Nitrite | Overweight maintained | ₹1,869 | ₹1,889 |
| Aarti Industries | Underweight to Equal-weight | ₹366 | ₹471 |
| PI Industries | Overweight to Underweight | ₹3,883 | ₹2,030 |
The PI Industries figures and rating transition were reported in secondary coverage and should be checked against Morgan Stanley's original report before publication. Price targets are estimates based on the brokerage's assumptions and should not be interpreted as assured future market prices.
Deepak Nitrite: Recovery Potential and Feedstock Risk
Morgan Stanley retained its Overweight rating on Deepak Nitrite and increased its price target by ₹20, from ₹1,869 to ₹1,889. The reported investment case centres on improved profitability in advanced intermediates and firm margins in phenolics, which could support an earnings recovery.
The brokerage also reportedly observed improved volumes and pricing power in the advanced-intermediates business. However, feedstock availability remains an important risk: shortages or unfavourable input costs could limit production and margins. Higher interest and depreciation expenses associated with investments could also affect earnings as new capacity is developed or commissioned.
The key question is whether improved operating performance can offset these costs. Investors assessing the business would need to distinguish reported improvements in volumes or pricing from sustained growth in profitability and cash generation.
Aarti Industries: Better Margins, but a Cautious Rating
Morgan Stanley upgraded Aarti Industries to Equal-weight from Underweight and raised its target to ₹471 from ₹366. The reported rationale includes stronger spreads for monomethyl aniline (MMA), potential support from tighter supply of certain chemical intermediates in China, and better utilisation as new capacity comes on stream.
MMA is used in chemical applications that include fuel additives. The brokerage's reported view also links demand prospects to gasoline spreads, which can influence economics for parts of the fuel-additives chain. If spreads and capacity utilisation improve, these factors could support operating margins.
The upgrade remains measured. Morgan Stanley reportedly expects returns to remain constrained and notes the growing contribution of the energy-related business to earnings. That concentration can leave results exposed to changes in refining conditions, fuel demand and the profitability of related products. An improved rating therefore does not mean all operating risks have disappeared.
PI Industries: Competition and Product-Ramp Challenges
PI Industries faces a less favourable outlook in the reported research. Morgan Stanley downgraded the stock to Underweight from Overweight, with secondary coverage reporting a target reduction from ₹3,883 to ₹2,030.
The central concern is increasing competition in the legacy agrochemical portfolio, including generic competition for pyroxasulfone, alongside a slower-than-expected ramp-up of newer products. New agrochemicals, biologicals and pharmaceutical products may take time to scale sufficiently to offset pressure on established products.
The report also reportedly identifies regulatory hurdles, adverse weather and slower product ramp-ups as factors that have constrained volume growth relative to peers and delayed margin recovery. Even if sales volumes improve during the second half of the financial year, competitive pricing and execution challenges could continue to influence profitability.
What the Divergence Means for the Sector
The three calls illustrate how demand conditions alone may not determine earnings performance. Deepak Nitrite's recovery depends partly on margins and feedstock access; Aarti Industries needs improved spreads and utilisation to translate into stronger returns; and PI Industries must manage competition while scaling newer products.
Chinese supply constraints and improving agrochemical demand may support selected businesses, but those factors do not affect every company equally. Product mix, pricing power, capital costs and execution remain important differentiators. The report's rating changes should be assessed alongside subsequent company results and disclosures rather than treated as a sector-wide signal.
For publication, the original Morgan Stanley report should be used to confirm the exact PI Industries rating and target, as well as the assumptions behind all three price targets. The available figures describe brokerage estimates as of the report date and do not establish future returns or actual earnings outcomes.
